AGP Picks
View all

Hottest science and technology news from New York

Provided by AGP

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on May 1, 2026

UTime Limited Announces Pricing of $1.2 Million Registered Direct Offering
Whitespace Makes Iris, AI Intelligence Analysis Agent, Generally Available to Authorized DoW and IC Users
Roadzen to Attend Nordics’ Leading Automotive Event VECS 2026 in Gothenburg on May 5–6
Broadwind Announces First Quarter 2026 Results Conference Call and Webcast Date
StellarSpace Unveils New-Generation Industrial Automation Products at Silicon Valley Launch Event
DRIVEN BRANDS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DRVN
Super Micro Computer, Inc. Investors Have Until May 26th to Contact Bragar Eagel & Squire, P.C. To Seek Lead Plaintiff Role
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
Free AI Crypto Trading App by AriseAlpha: Smart Automated Trading in 2026
Swift Seed Micro Launches Blockchain-Powered Micro-Financing Initiative for Emerging Markets
Bitdeer Announces First Quarter 2026 Earnings Conference Call for May 14th 2026
Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
Transforming Complex Systems Through Design: An Upcoming Feature on Sparshita Das by New York Art Life Magazine
Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29th
SLNO 4-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions – Hagens Berman
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm
DEADLINE ALERT for GOSS, NUAI, and MEDP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman
IBRX SHAREHOLDER UPDATE: ImmunityBio (IBRX) Sued After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- Hagens Berman

Share us

on your social networks:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.